Fungemia in Hematologic Malignancies
NCT02451592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2016-10-20
Summary
The purpose of this study is to determine the risk factors for fungemia in a population of patients diagnosed with hematologic malignancies and eligible for chemotherapy.
Conditions
- Acute Leukemia
- Chronic Leukemia
- Multiple Myeloma
- Lymphoma
Sponsors & Collaborators
-
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
lead OTHER
Principal Investigators
-
Livio Pagano, Professor · Catholic University of Sacred Heart, Rome Italy
Eligibility
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-01-31
Countries
- Italy
Study Locations
More Related Trials
-
Role of Antifungal Prophylaxis in Elderly Patients With Acute Myeloid Leukemia During Consolidation Therapy
NCT06382922 ·Status: RECRUITING
-
Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy
NCT03221075 ·Status: COMPLETED
-
Fungal Infections in Patients With Hematological Malignancies
NCT03650439 ·Status: UNKNOWN
-
A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation
NCT01519648 ·Status: COMPLETED
-
Diagnostic and Management Strategies for Invasive Aspergillosis
NCT00816088 ·Status: COMPLETED
-
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
NCT00462657 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
NCT04738955 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology
NCT02127788 ·Status: COMPLETED
-
Empirical Versus Preemptive Antifungal Therapy
NCT01288378 ·Status: COMPLETED ·Phase: PHASE3
-
Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI)
NCT04720144 ·Status: UNKNOWN
-
Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis
NCT03349931 ·Status: COMPLETED
-
Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers
NCT00906633 ·Status: COMPLETED
-
Breath Analysis for the Detection of Invasive Fungal Infections
NCT06537726 ·Status: RECRUITING
-
Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
NCT02492594 ·Status: COMPLETED
-
Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.
NCT02851680 ·Status: COMPLETED ·Phase: NA
-
Mucorales PCR Screening in At-risk Hematology Patients
NCT05925660 ·Status: UNKNOWN ·Phase: NA
-
Prophylaxis of Fungal Invasive Infections in Leukemia
NCT00501098 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised Patients
NCT01902030 ·Status: UNKNOWN
-
New Biomarkers for Invasive Fungal Infections in Paediatric Haemato-oncology
NCT02587377 ·Status: TERMINATED ·Phase: NA
-
Retrospective Chart Review of Candida Fungemia
NCT03827330 ·Status: COMPLETED
-
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
NCT01307579 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of Serum and/or Plasma Biomarkers for the Diagnosis Prognosis and/or Prediction of Invasive Mycosis in Neutropenic Patients
NCT01907477 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients
NCT01695512 ·Status: UNKNOWN
-
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
NCT00336531 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Duration of IPA
NCT06583512 ·Status: ACTIVE_NOT_RECRUITING